Literature DB >> 6223417

Immunomodulating influence of active metabolite of cyclophosphamide on human lymphocyte immunoglobulin biosynthesis in vitro.

A Górski, M Nowaczyk, G Korczak-Kowalska, W Rowiński.   

Abstract

4-hydroxycyclophosphamide (4HCy) inhibits T cell-dependent and direct B cell humoral responses of human lymphocytes in vitro, but causes a potentiation of the former in the lowest drug concentrations. Lymph node humoral responses are strongly sensitive, but those of spleen are relatively resistant to the drug. Although the induction of suppressor T cells is Cy-resistant, the expression of their function is sensitive. The suppressor cell function of antibody production appears to be more sensitive than the helper function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223417     DOI: 10.1097/00007890-198306000-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  1 in total

1.  Inhibition of human B lymphocyte differentiation by a stable metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide).

Authors:  A Gorski; G Korczak-Kowalska
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.